With September rounding out quarter three, we’ve compiled the top healthcare stories from this month for busy healthcare marketing and PR professionals.
Many mergers and acquisitions make up this month’s headlines from companies including CVS Health, Amazon and UnitedHealth Group. On the COVID-19 front, the development of reformulated vaccines has been approved by the FDA to target variants of the virus. And as we look to 2023, expect healthcare costs to rise as a result of rising inflation and labor costs.
M&A NEWS
Despite the Justice Department’s attempt to halt the deal earlier this year, UnitedHealth Group has been cleared by a Washington DC federal judge to move forth with the $7.8 billion acquisition of Change Healthcare.
HEALTHCARE COSTS
Long-term care to be out of reach for many by 2033
According to a new poll, almost one in five Americans (18%) have skipped their medical appointments or stopped filling prescriptions due to financial constraints. Thirty percent of these poll participants reported making less than $25,000 a year.
Inflation, Labor Costs Will Increase Healthcare Spending by $370B
Despite consumer prices rising faster than healthcare inflation, according to a McKinsey report, in the next five years, inflation and labor costs will increase US national healthcare spending by $370 billion. Researchers expect $170 billion be attributed to rising clinical costs and $90 billion to nonclinical labor costs by 2027.
PUBLIC HEALTH
FDA authorizes COVID-19 vaccines targeted at variants